Jacob Hill1,2, Ryan Seguin3, Agness Manda3, Maria Chikasema3, Olivia Vaz4, Quefeng Li4, Hannan Yang4, Satish Gopal5, Jennifer S Smith4. 1. University of North Carolina, Chapel Hill, 101 Manning Dr., Chapel Hill, NC, 27599, USA. Jacob.hill@nyulangone.org. 2. Program on Integrative Medicine, University of North Carolina, 101 Manning Dr., Chapel Hill, NC, 27599, USA. Jacob.hill@nyulangone.org. 3. Malawi Cancer Consortium and Regional Center of Research Excellence for Non-Communicable Diseases, Tidziwe Centre, Private Bag A-104, Lilongwe, Malawi. 4. University of North Carolina, Chapel Hill, 101 Manning Dr., Chapel Hill, NC, 27599, USA. 5. Center for Global Health, National Cancer Institute, National Institutes of Health, 9609 Medical Center Dr, Rockville, MD, 20850, USA.
Abstract
PURPOSE: The objective of this study is to document the prevalence of traditional, complementary, and alternative medicine (TCAM) use by adult cancer patients at a national teaching hospital in Malawi. We aim to document the products/therapies used, the reason for use, as well as patient-reported satisfaction with TCAM practitioners and modalities. METHODS: We conducted investigator-administered interviews with adult cancer patients presenting to the Kamuzu Central Hospital (KCH) Cancer Clinic in Lilongwe, Malawi between January and July 2018. The KCH is a national teaching hospital in the capital of Lilongwe, which serves patients with cancer from the northern half of Malawi. Descriptive statistics were used to describe TCAM use and logistic regression was applied to identify predictors of TCAM. RESULTS: A total of 263 participants completed the survey, of which 70% (n = 183) were female and average age was 45 (SD 14) years old. The prevalence of overall TCAM use was 84% (n = 222), and 60% (n = 157) of participants reported combining TCAM with conventional cancer treatment. The majority of patients used TCAM to directly treat their cancer versus for symptom management. Patients reported using faith-based healing (64%, n = 168), herbal medicine (56%, n = 148), diet change (46%, n = 120), and vitamins/minerals (23%, n = 61). Participants reported the highest satisfaction for physicians among practitioners and diet change for modalities. Female gender was found to be a predictor of TCAM with conventional treatment use, no other significant predictors were observed. CONCLUSION: There is a high prevalence of TCAM use among an adult population with cancer in Malawi, and a wide variety in the TCAM modalities used among patients. Additional studies are needed to identify risks and benefits of TCAM use to assist with policy and public health, patient safety, and holistically address the global burden of cancer.
PURPOSE: The objective of this study is to document the prevalence of traditional, complementary, and alternative medicine (TCAM) use by adult cancer patients at a national teaching hospital in Malawi. We aim to document the products/therapies used, the reason for use, as well as patient-reported satisfaction with TCAM practitioners and modalities. METHODS: We conducted investigator-administered interviews with adult cancer patients presenting to the Kamuzu Central Hospital (KCH) Cancer Clinic in Lilongwe, Malawi between January and July 2018. The KCH is a national teaching hospital in the capital of Lilongwe, which serves patients with cancer from the northern half of Malawi. Descriptive statistics were used to describe TCAM use and logistic regression was applied to identify predictors of TCAM. RESULTS: A total of 263 participants completed the survey, of which 70% (n = 183) were female and average age was 45 (SD 14) years old. The prevalence of overall TCAM use was 84% (n = 222), and 60% (n = 157) of participants reported combining TCAM with conventional cancer treatment. The majority of patients used TCAM to directly treat their cancer versus for symptom management. Patients reported using faith-based healing (64%, n = 168), herbal medicine (56%, n = 148), diet change (46%, n = 120), and vitamins/minerals (23%, n = 61). Participants reported the highest satisfaction for physicians among practitioners and diet change for modalities. Female gender was found to be a predictor of TCAM with conventional treatment use, no other significant predictors were observed. CONCLUSION: There is a high prevalence of TCAM use among an adult population with cancer in Malawi, and a wide variety in the TCAM modalities used among patients. Additional studies are needed to identify risks and benefits of TCAM use to assist with policy and public health, patient safety, and holistically address the global burden of cancer.
Authors: Gabriella M John; Dawn L Hershman; Laura Falci; Zaixing Shi; Wei-Yann Tsai; Heather Greenlee Journal: J Cancer Surviv Date: 2016-02-26 Impact factor: 4.442
Authors: John W Stanifer; Uptal D Patel; Francis Karia; Nathan Thielman; Venance Maro; Dionis Shimbi; Humphrey Kilaweh; Matayo Lazaro; Oliver Matemu; Justin Omolo; David Boyd Journal: PLoS One Date: 2015-04-07 Impact factor: 3.240
Authors: Massimiliano Berretta; Chiara Della Pepa; Paolo Tralongo; Alberto Fulvi; Ferdinando Martellotta; Arben Lleshi; Guglielmo Nasti; Rossella Fisichella; Carmela Romano; Chiara De Divitiis; Rosaria Taibi; Francesco Fiorica; Raffaele Di Francia; Anna Di Mari; Lino Del Pup; Anna Crispo; Paolo De Paoli; Adriano Santorelli; Vincenzo Quagliariello; Rosario Vincenzo Iaffaioli; Umberto Tirelli; Gaetano Facchini Journal: Oncotarget Date: 2017-04-11
Authors: Kathrin Wode; Roger Henriksson; Lena Sharp; Anna Stoltenberg; Johanna Hök Nordberg Journal: BMC Complement Altern Med Date: 2019-03-13 Impact factor: 3.659
Authors: Joseph Lunyera; Daphne Wang; Venance Maro; Francis Karia; David Boyd; Justin Omolo; Uptal D Patel; John W Stanifer Journal: BMC Complement Altern Med Date: 2016-08-11 Impact factor: 3.659